PubRank

Alexandra Belayew

Author PubWeight™ 26.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci U S A 2007 3.32
2 The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord 2007 2.85
3 An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J 2008 2.74
4 DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol 2010 1.89
5 DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Exp Neurol 2008 1.48
6 The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS One 2011 1.45
7 DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS One 2009 1.12
8 DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? J Cell Mol Med 2012 1.06
9 Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Hum Genet 2011 1.04
10 A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology. J Biomol Screen 2006 0.99
11 Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction. Free Radic Biol Med 2012 0.99
12 Intracellular trafficking and dynamics of double homeodomain proteins. Biochemistry 2005 0.95
13 The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy. J Biol Chem 2011 0.91
14 DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells. PLoS One 2013 0.88
15 Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients. J Biol Chem 2013 0.85
16 The helicase-like transcription factor is a strong predictor of recurrence in hypopharyngeal but not in laryngeal squamous cell carcinomas. Histopathology 2009 0.79
17 FSHD myotubes with different phenotypes exhibit distinct proteomes. PLoS One 2012 0.78
18 Expression of the helicase-like transcription factor and its variants during carcinogenesis of the uterine cervix: implications for tumour progression. Histopathology 2011 0.78
19 Early expression of the Helicase-Like Transcription Factor (HLTF/SMARCA3) in an experimental model of estrogen-induced renal carcinogenesis. Mol Cancer 2006 0.77
20 Helicase-like transcription factor exhibits increased expression and altered intracellular distribution during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas. Virchows Arch 2008 0.76
21 Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers. BMC Cancer 2014 0.75
22 Measurement of translesion synthesis by fluorescent capillary electrophoresis: 7,8-dihydro-8-oxodeoxyguanosine bypass modulation by natural products. Anal Biochem 2013 0.75
23 The helicase-like transcription factor (HLTF) in cancer: loss of function or oncomorphic conversion of a tumor suppressor? Cell Mol Life Sci 2016 0.75
24 On-chip microelectrophoresis for the study of in vitro nonhomologous end-joining DNA double-strand break repair. Anal Biochem 2012 0.75